http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2007913-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a3d4ccde8e11b6f69de59500cc1b299
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
filingDate 1990-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f04b7149fb762b0f03eb2e345c52b57f
publicationDate 1990-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2007913-A1
titleOfInvention Composition and treatment with peptide combinations
abstract ABSTRACT OF THE DISCLOSURE A composition comprising a magainin peptide or an analogue or derivative thereof, and at least one member selected from the group consisting of a PGLa peptide or analogue or derivative thereof, and an XPF peptide or analogue or derivative thereof. The composition is employed as a pharmaceutical.
priorityDate 1989-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601030
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5476

Total number of triples: 21.